
Want an Appointment ?
Please feel Welcome to contact us and we will book your appointment in seconds.
DHCC +971 4429 7777
SZRMC +971 4581 3333
Biography
Speciality
Consultant Medical Oncology
Degrees
• French Board certified in Medical Oncology
• French Board certified in Clinical Hematology
• Postdoctoral Fellowship, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA
• Former Senior Consultant, Gustave Roussy Cancer Center, Villejuif, France
• University Diploma, Allogeneic Hematopoietic Stem Cell Transplantation, University of Paris VI School of Medicine, Pierre-et-Marie-Curie, Paris, France (2014).
• ECGMG Certification USMLE (Step 1, Step 2 CS), Educational Commission for Foreign Medical Graduates, Philadelphia, PA, USA (2015).
• University Diploma, Personalized Medicine and Pharmacogenomics, University of Paris VI School of Medicine, Pierre-et-Marie-Curie, Paris, France (2017).
• Master of Science 2 (MSc) in Clinical Research, University of Paris VI School of Medicine, Pierre-et-Marie-Curie, Paris, France (2017).
• University Diploma, Immuno-Oncology, University of Paris XI School of Medicine, Paris, France (2019).
• PhD, awarded “Summa Cum Laude” with recommendation from the committee, University of Paris Saclay, Paris, France (2021).
Areas of Expertise
• Gastrointestinal cancers (Oesophageal cancer, Gastric (stomach) cancer, Colorectal cancer, Pancreatic cancer, Liver cancer, Bile duct, Neuroendocrine and Carcinoid Tumours)
• Breast cancer
• Genitourinary cancers (Prostate, Bladder, Kidney, Testicular, and Urethral)
• Lung cancer
• Gynaecologic cancers (Cervical, Ovarian, Uterine, Vaginal, and Vulvar)
• Central nervous system (Brain) cancers
• Soft-tissue sarcomas
• Lymphomas
• Palliative and supportive care in cancer patients
• Clinical trials
Precision oncology with :
– The development of a patient-centric and personalized treatment approaches in cancer patients.
– The identification of predictive markers for a better benefit-risk balance of anticancer drugs.
– The implementation of liquid biopsy in cancer patients for a better molecular characterization of cancers for diagnosis, patient stratification to therapy, and longitudinal monitoring.
Focus on:
– Developing patient-centric and personalized cancer treatment approaches.
– Identifying predictive markers for a better benefit-risk balance of anticancer drugs.
– Implementing cancer awareness campaigns and holistic patient programs to provide comprehensive cancer care.
– Addressing patients’ physical, emotional, and psychosocial needs alongside cutting-edge medical interventions.
Procedures
• Chemotherapy administration and monitoring.
• Immunotherapy administration and monitoring.
• Targeted therapy / TKIs.
• Endocrine therapy.
• Personalized medicine.
• Oncologic emergencies.
• Patient education and counselling.
• Survivorship care.
• Cancer prevention.
• Cancer screening.
• Bone marrow biopsy and aspiration.
• Palliative care and cancer-related symptom management.